HIV test maker lures Pfizer marketer for TV push

Share this article:
HIV test maker lures Pfizer marketer for TV push
HIV test maker lures Pfizer marketer for TV push

OraSure, the maker of the recently approved home HIV test, has hired an experienced consumer marketer from Pfizer to head up the launch for the product.

The Bethlehem, PA-based diagnostics firm named Kathleen G. Weber SVP and general manager, consumer products. Weber will preside over the commercialization of OraSure's lead product, the OraQuick In-Home HIV Test, which won FDA approval in July. The $39 test, which offers users results in 20 minutes based on a saliva swab, is the first home HIV test to hit the market.

Weber joins OraSure from Pfizer Consumer Healthcare, where she was SVP and led the company's global Rx-to-OTC switch team, along with its $700 million analgesics and respiratory business. She had previously worked at J&J, where she headed up the $1.3 billion oral care and sanitary protection categories for Listerine, REACH, Stayfree and Carefree, and worked on the OTC switch of Claritin at Schering-Plough.

The OraQuick test hit store shelves in September, and the company began a PR push, orchestrated by agencies Golin Harris and Zer0 to 5ive, in October, with appearances by Magic Johnson and, on October 15, to coincide with National Latino AIDS Awareness Day, former Miss Venezuela and Miss Universe Dayana Mendoza. TV ads launched on Dec. 1 on cable networks including MTV, A&E, BET, E!, Bravo and Logo, and also aired on the Dec. 17 edition of the NBC reality show The Voice.

The TV ads, which are by Princeton agency Ferrara & Co., bear the tagline: “Knowing is the best thing.” Initially, the company is targeting the gay, African American and Latino communities with the ads.  Print and banner ads will also run as part of the campaign.

“The core message is around normalizing HIV testing and creating a feeling of inclusion and acceptance,” said Ron Ticho, SVP of corporate communications at OraSure. “It's very non-judgmental. We wanted the tone to be serious but friendly and warm.”

In addition to OraQuick, the company makes a rapid hepatitis C test, a line of swab tests for drug abuse and a cryosurgery medical device for wart removal.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?